On this week’s Tech Nation, Moira speaks with Journalist Vauhini Vara about her book, “Searches: Selfhood in the Digital Age”, which examines how the internet and AI influence who we are.
Then, linguist Dr. Emily Bender and ethical AI researcher Dr. Alex Hanna discuss their book, “The AI Con … How to Fight Big Tech’s Hype and Create the Future We Want”.

On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, about a breakthrough in neuroscience that leads to a new therapy showing lasting success in epilepsy. There's potential for Parkinson's, Alzheimer's, PTSD, and more.

On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, about a breakthrough in neuroscience that leads to a new therapy showing lasting success in epilepsy. There's potential for Parkinson's, Alzheimer's, PTSD, and more.

On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, about a breakthrough in neuroscience that leads to a new therapy showing lasting success in epilepsy. There's potential for Parkinson's, Alzheimer's, PTSD, and more.

On this week’s Tech Nation, Moira speaks with Marine biologist Dr. Drew Harvell about her new book, "The Ocean’s Menagerie: How Earth’s Strangest Creatures Reshape the Rules of Life." Then, Sameer Sabir, CEO of Brixton Biosciences, explains their new injectable cold therapy in trials for knee pain. And, Erica Dhawan returns to explore the impact of tone in digital communication and why it often goes unnoticed.

On this week’s Tech Nation, Moira speaks with Marine biologist Dr. Drew Harvell about her new book, "The Ocean’s Menagerie: How Earth’s Strangest Creatures Reshape the Rules of Life." Then, Sameer Sabir, CEO of Brixton Biosciences, explains their new injectable cold therapy in trials for knee pain. And, Erica Dhawan returns to explore the impact of tone in digital communication and why it often goes unnoticed.

On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.

On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.